Gastrocnemius muscle
|
2 week |
Olfactory transduction |
Clca3 (6), Olfr739 (14), Olfr488 (40), Olfr474 (55) |
4 week |
Olfactory transduction |
Olfr800 (28), Olfr978 (33), Olfr474 (49), Olfr488 (73) |
|
Neuroactive ligand-receptor interaction |
Oprl1 (30), Mc1r (78), Tbxa2r (89), Tspo (97) |
|
Cytokine-cytokine receptor interaction |
Eda2r (2), Il13 (3), Cx3cl1 (91) |
|
Pathways in cancer |
Dcc (10), Amn (71), Mlh1 (85) |
8 week |
Olfactory transduction |
Clca3 (9), Olfr739 (48), Olfr1305 (64), Olfr1395 (80), Olfr140 (81), Olfr63 (85), Olfr689 (86) |
|
Pathways in cancer |
Mapk9 (4), Dcc (15), Mapk10 (78), Grb2 (87), Mitf (89) |
|
Insulin signaling pathway |
Mapk9 (4), Irs3 (40), Mapk10 (78), Grb2 (87) |
|
Colorectal cancer |
Mapk9 (4), Dcc (15), Mapk10 (78), Grb2 (87) |
|
Adipocytokine signaling pathway Type II diabetes mellitus |
Mapk9 (4), Irs3 (40), Mapk10 (78) |
12 week |
Olfactory transduction |
Olfr689 (22), Olfr488 (24), Olfr347 (38), Olfr1204 (69) |
|
Cell adhesion molecules (CAMs) |
Cd22 (23), Nlgn3 (44), Ptprm (62) |
|
Cytokine-cytokine receptor interaction |
Eda2r (43), Ppbp (53), Cx3cl1 (57) |